Respiratory syncytial virüs infections in neonates and infants

Yıldız Perk1, Mine Özdil1

  • 1Department of Pediatrics, Division of Neonatology, İstanbul University Cerrahpaşa School of Medicine, İstanbul, Turkey.

Turk Pediatri Arsivi
|August 18, 2018
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe infant respiratory infections, leading to hospitalizations and mortality. Currently, immunoprophylaxis with palivizumab is the only preventive measure for high-risk infants.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a primary cause of infant respiratory tract infections.
  • It leads to high hospitalization and mortality rates in young children, being a leading cause of bronchiolitis and pneumonia.
  • RSV is also linked to recurrent wheezing and pediatric asthma.

Purpose of the Study:

  • To highlight the severity and impact of RSV infections in infants.
  • To underscore the lack of specific treatments and vaccines for RSV.
  • To emphasize the role of immunoprophylaxis in managing severe RSV cases.

Main Methods:

  • Review of existing literature on RSV epidemiology and clinical impact.
  • Analysis of current therapeutic and preventive strategies for RSV.
  • Identification of high-risk populations susceptible to severe RSV infection.

Main Results:

  • RSV is a significant global health concern, particularly for infants under two.
  • High-risk infants (prematurity, congenital heart disease, immune deficiencies) face severe outcomes.
  • No specific antiviral treatment or vaccine is currently available for RSV.

Conclusions:

  • Severe RSV cases necessitate supportive care like oxygen and hydration.
  • Palivizumab immunoprophylaxis remains the sole option for reducing severe RSV morbidity in high-risk infants.
  • Further research is needed for effective RSV prevention and treatment strategies.

Related Concept Videos

What are Viruses?00:50

What are Viruses?

Overview
128.3K
Anatomy of Respiratory System II: Lower Respiratory Tract01:31

Anatomy of Respiratory System II: Lower Respiratory Tract

The lower respiratory tract is anatomically composed of several vital structures, including the larynx, trachea, bronchial tree, alveoli, lungs, and pleurae. Each component has a specific function, and all are intricately connected to ensure efficient respiration.
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
3.8K
The Respiratory System01:16

The Respiratory System

The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
89.5K
Anatomy of Respiratory System I: Upper Respiratory Tract01:29

Anatomy of Respiratory System I: Upper Respiratory Tract

The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
5.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
307
Respiratory Capacities01:24

Respiratory Capacities

Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
1.5K